(RTTNews) – ImmunoGen, Inc. (IMGN), announced on Wednesday that Renee Lentini, vice president of finance and chief accounting officer, has been named interim chief financial officer.
The appointment was made after Susan Altschuller, senior vice president and chief financial officer, went on leave under the Family and Medical Leave Act (FMLA). Altschuller will not continue his employment with ImmunoGen at the end of his furlough.
The company said it would seek Altschuller’s permanent replacement.
“On behalf of the Board of Directors, I thank Susan for her contributions to the business and wish her the best. We have a strong financial team in place to support the business and will move quickly to initiate the search for a new director. financial,” said Mark Enyedy, President and CEO of ImmunoGen. “With the recent FDA approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for platinum-resistant ovarian cancer, our top priority is to execute the U.S. launch with excellence and we look forward to look forward to a promising year as we build a strong start in bringing it to market and advancing our pipeline of new ADCs.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.